Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to criticisms

 COVID-IHU #39

Version 1 du 24 septembre 2020
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to criticisms
Didier Raoult, Matthieu Million, Jean-Christophe Lagier, Philippe Colson, Philippe Parola, Jean-Marc Rolain, Philippe Gautret

Lire l’article
Figure 1A
Figure 1B
Supplement data

> Retour vers la page PRE-PRINTS